Natural Killer cells as COVID-19 therapy

Natural Killer cells as COVID-19 therapy

Show other versions (1)
Saved in:
Bibliographic Details
Other Authors: Kennedy, Pippa (Speaker)
Format: Electronic Audio
Language:English
Published: London : Henry Stewart Talks, 2020.
Series:Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
Subjects:
Clinical trials.
COVID-19 (Disease) > Treatment.
Killer cells > Therapeutic use.
Natural immunity.
Clinical Trials, Phase I as Topic.
Coronavirus Infections > drug therapy.
Coronavirus Infections > immunology.
COVID-19 > therapy.
Induced Pluripotent Stem Cells.
Killer Cells, Natural > drug effects.
Killer Cells, Natural > immunology.
Pneumonia, Viral > drug therapy.
Pneumonia, Viral > immunology.
SARS-CoV-2.
Virus Diseases > immunology.
Online Access:Series
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nim a2200000 a 4500
001 HST8205
003 UkLoHST
006 m o h
007 cr nna||||||||
007 sr |mnnnnnzne|
008 201204s2020 enk|||||o||h||||||||eng d
028 5 0 |a 8205  |b Henry Stewart Talks 
035 |a (UkLoHST)4473 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Kennedy, Pippa,  |u (University of Minnesota, USA)  |4 spk  |9 87840 
245 1 0 |a Natural Killer cells as COVID-19 therapy  |h [electronic resource] /  |c an interview with Pippa Kennedy. 
260 |a London :  |b Henry Stewart Talks,  |c 2020. 
300 |a 1 online resource (1 streaming audio file (14 min.)). 
490 1 |a Interviews on Covid-19,  |x 2056-452X 
500 |a Audio interview. 
500 |a Title from title frames. 
505 0 |a Contents: The role of Natural Killer (NK) cells in viral infections -- Why NK cells are being investigated -- Induced pluripotent stem cell derived natural killer cells for SARS-CoV-2 therapy -- Benefits of this therapy -- Current stage of the clinical trial. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Clinical trials.  |9 87841 
650 0 |a COVID-19 (Disease)  |x Treatment.  |9 87842 
650 0 |a Killer cells  |x Therapeutic use.  |9 87843 
650 0 |a Natural immunity.  |9 87844 
650 2 |a Clinical Trials, Phase I as Topic.  |9 87845 
650 2 |a Coronavirus Infections  |x drug therapy.  |9 87846 
650 2 |a Coronavirus Infections  |x immunology.  |9 87847 
650 2 |a COVID-19  |x therapy.  |9 87848 
650 2 |a Induced Pluripotent Stem Cells.  |9 87849 
650 2 |a Killer Cells, Natural  |x drug effects.  |9 87850 
650 2 |a Killer Cells, Natural  |x immunology.  |9 87851 
650 2 |a Pneumonia, Viral  |x drug therapy.  |9 87852 
650 2 |a Pneumonia, Viral  |x immunology.  |9 87853 
650 2 |a SARS-CoV-2.  |9 87854 
650 2 |a Virus Diseases  |x immunology.  |9 87855 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Interviews on Covid-19.   |9 87856 
856 4 0 |a https://hstalks.com/bs/4473/ 
856 4 2 |u https://hstalks.com/bs/p/1060/  |3 Series 
999 |c 213920  |d 213919 

Similar Items